Dr. Reddy's Laboratories Ltd. ADR sell Jefferies Financial Group Inc.
Start price
11.01.24
/
50%
€62.50
Target price
11.01.25
-
Performance (%)
-76.16%
End price
12.01.25
€14.90
Summary
This prediction ended on 12.01.25 with a price of €14.90. Jefferies_Financial_ correctly predicted massive losses of -76.16% for Dr. Reddy's Laboratories Ltd. ADR. Dividends of €0.44 are taken into consideration when calculating the performance. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dr. Reddy's Laboratories Ltd. ADR | 1.923% | 1.923% | -13.115% |
| iShares Core DAX® | 0.437% | 5.640% | 7.806% |
| iShares Nasdaq 100 | 1.057% | 0.282% | 27.239% |
| iShares Nikkei 225® | 1.769% | 0.406% | 49.266% |
| iShares S&P 500 | 0.368% | 1.920% | 22.336% |
Comments by Jefferies_Financial_ for this prediction
In the thread Dr. Reddy's Laboratories Ltd. ADR diskutieren
Dr. Reddy's Laboratories Limited (NYSE: RDY) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to an "underperform" rating.
Ratings data for RDY provided by MarketBeat
In the thread Trading Dr. Reddy's Laboratories Ltd. ADR
Die von Jefferies_Financial_ gewählte maximale Laufzeit wurde überschritten